GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nyxoah SA (XBRU:NYXH) » Definitions » Beneish M-Score

Nyxoah (XBRU:NYXH) Beneish M-Score

: -1.59 (As of Today)
View and export this data going back to 2020. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.59 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Nyxoah's Beneish M-Score or its related term are showing as below:

XBRU:NYXH' s Beneish M-Score Range Over the Past 10 Years
Min: -1.59   Med: -1.08   Max: -0.57
Current: -1.59

During the past 7 years, the highest Beneish M-Score of Nyxoah was -0.57. The lowest was -1.59. And the median was -1.08.


Nyxoah Beneish M-Score Historical Data

The historical data trend for Nyxoah's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyxoah Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Premium Member Only Premium Member Only - - - -0.57 -1.59

Nyxoah Quarterly Data
Dec17 Dec18 Jun19 Dec19 Mar20 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.57 -1.71 -1.81 -1.58 -1.59

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Nyxoah's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nyxoah Beneish M-Score Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Nyxoah's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Nyxoah's Beneish M-Score falls into.



Nyxoah Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Nyxoah for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.3082+0.528 * 1.0125+0.404 * 1.4001+0.892 * 1.4094+0.115 * 1.1206
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8164+4.679 * 0.020055-0.327 * 1.1877
=-1.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was €5.97 Mil.
Revenue was 1.824 + 0.976 + 1.107 + 0.441 = €4.35 Mil.
Gross Profit was 1.098 + 0.64 + 0.688 + 0.266 = €2.69 Mil.
Total Current Assets was €68.35 Mil.
Total Assets was €124.16 Mil.
Property, Plant and Equipment(Net PPE) was €7.98 Mil.
Depreciation, Depletion and Amortization(DDA) was €2.36 Mil.
Selling, General, & Admin. Expense(SGA) was €20.64 Mil.
Total Current Liabilities was €14.44 Mil.
Long-Term Debt & Capital Lease Obligation was €11.49 Mil.
Net Income was -10.893 + -7.612 + -12.797 + -11.911 = €-43.21 Mil.
Non Operating Income was -0.826 + 0.602 + -0.259 + -0.442 = €-0.93 Mil.
Cash Flow from Operations was -11.678 + -10.622 + -11.81 + -10.668 = €-44.78 Mil.
Total Receivables was €3.24 Mil.
Revenue was 1.307 + 0.182 + 0.936 + 0.66 = €3.09 Mil.
Gross Profit was 0.842 + 0.119 + 0.602 + 0.371 = €1.93 Mil.
Total Current Assets was €100.26 Mil.
Total Assets was €146.07 Mil.
Property, Plant and Equipment(Net PPE) was €5.62 Mil.
Depreciation, Depletion and Amortization(DDA) was €1.93 Mil.
Selling, General, & Admin. Expense(SGA) was €17.94 Mil.
Total Current Liabilities was €14.91 Mil.
Long-Term Debt & Capital Lease Obligation was €10.78 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(5.97 / 4.348) / (3.238 / 3.085)
=1.373045 / 1.049595
=1.3082

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1.934 / 3.085) / (2.692 / 4.348)
=0.626904 / 0.619135
=1.0125

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (68.351 + 7.976) / 124.157) / (1 - (100.26 + 5.619) / 146.071)
=0.385238 / 0.275154
=1.4001

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=4.348 / 3.085
=1.4094

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.932 / (1.932 + 5.619)) / (2.36 / (2.36 + 7.976))
=0.25586 / 0.228328
=1.1206

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(20.644 / 4.348) / (17.941 / 3.085)
=4.74793 / 5.815559
=0.8164

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((11.489 + 14.443) / 124.157) / ((10.775 + 14.913) / 146.071)
=0.208865 / 0.17586
=1.1877

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-43.213 - -0.925 - -44.778) / 124.157
=0.020055

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Nyxoah has a M-score of -1.59 signals that the company is likely to be a manipulator.


Nyxoah (XBRU:NYXH) Business Description

Traded in Other Exchanges
Address
Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.